13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2015-06-30, filed 2015-08-14, with 46 holding rows worth $251,326,000.
- Accession
- 0001546927-15-000231
- Filer
- CIK 1595855
- Filed
- 2015-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2015
A holdings report, 46 entries on the cover page, a total value of $251,326,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $251,326,000 with VALUE read as thousands by filing date, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CHIMERIX INC COM | 16934W106 | Stock | 440,000 | $20,328,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 490,000 | $16,836,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 460,000 | $15,249,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 190,000 | $13,121,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 1,500,000 | $12,405,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 110,000 | $11,263,000 | thousands by filing date | |
| IMPRIMIS PHARMA IMMY | 45323A201 | COMMON | 1,205,000 | $9,797,000 | thousands by filing date | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 535,000 | $9,084,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 590,300 | $7,951,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 90,000 | $7,909,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 1,825,000 | $7,811,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 325,000 | $7,638,000 | thousands by filing date | |
| MIMEDX GROUP INC | 602496101 | COM | 617,000 | $7,151,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 145,000 | $6,925,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 1,724,000 | $6,706,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 2,120,000 | $6,657,000 | thousands by filing date | |
| FLAMEL TECHNOLOGIES-SP ADR | 338488109 | SPON | 310,000 | $6,569,000 | thousands by filing date | |
| Medgenics Inc New | 58436Q203 | COM NEW | 1,050,000 | $6,437,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 105,000 | $5,487,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 250,000 | $5,455,000 | thousands by filing date | |
| ZS PHARMA INC | 98979G105 | Common Stock | 95,000 | $4,977,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365AAB7 | NOTE 4.500% 9/1 | 2,505,000 | $4,885,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,754,000 | $4,315,000 | thousands by filing date | |
| CARA THERAPEUTICS INC | 140755109 | COM | 340,000 | $4,131,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 50,000 | $4,043,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 150,000 | $3,933,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 90,000 | $3,417,000 | thousands by filing date | |
| INSYS THERAPEUTICS INC | 45824V209 | COMMON STOCK | 89,000 | $3,197,000 | thousands by filing date | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 65,000 | $3,084,000 | thousands by filing date | |
| ITEK 5 02/15/20 | 45780VAA0 | Bond 30/360P2 U | 604,700 | $2,963,000 | thousands by filing date | |
| AVINGER INC | 053734109 | COM | 208,200 | $2,688,000 | thousands by filing date | |
| Accelerate Diagnostics | 00430H102 | COM | 100,600 | $2,596,000 | thousands by filing date | |
| XOMA CORP DEL | 98419J107 | COM | 650,000 | $2,522,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 635,000 | $2,343,000 | thousands by filing date | |
| AURIS MED HLDG AG | H03579101 | COM | 355,000 | $1,725,000 | thousands by filing date | |
| TONIX PHARMACEUTICALS HOLDING | 890260201 | COM NEW | 190,000 | $1,704,000 | thousands by filing date | |
| ZOGENIX INC | 98978L105 | COM | 912,500 | $1,533,000 | thousands by filing date | |
| Innocoll | 45780Q103 | SPONDS ADR | 101,200 | $1,481,000 | thousands by filing date | |
| EVOKE PHARMA INC | 30049G104 | COM | 259,100 | $1,355,000 | thousands by filing date | |
| CELGENE CORP | 151020112 | RIGHT 12/31/2030 | 456,492 | $950,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 85,000 | $871,000 | thousands by filing date | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 250,000 | $495,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 55,000 | $472,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 26,000 | $399,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 18,800 | $330,000 | thousands by filing date | |
| TRACON PHARMACEUTICALS INC | 89237H10A | COM | 12,172 | $138,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001546927-15-000231 | this filing | 2015-08-14 | acceptance time not in the bulk data set |